← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cytonus Therapeutics, Inc.
Columbus, OH
$3,905,661
Total funding
6
Grants
Funding over time
peak $1.1M · FY2020–24$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,905,661 · 6
By mechanism
R44$2,042,215 · 1
R41$1,110,918 · 3
R43$752,528 · 2
Investigators at Cytonus Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of CA-IL-12 for Triple Negative Breast Cancer$1,148,542
R44 · FY2023 · CA
Development of CA-IL-12 for Triple Negative Breast Cancer$893,673
R44 · FY2024 · CA
Therapeutic platform to treat disease lung using enucleated mesenchymal stem cells0/01/2021$454,975
R43 · FY2021 · HL
Development of a Novel Therapeutic Transporter to Treat Metastatic Cancers$399,346
R41 · FY2020 · CA
Development of CA-IL-12 for Triple Negative Breast Cancer$386,586
R41 · FY2020 · CA
Bioengineering a Novel Therapeutic Transporter that Crosses the Blood Brain Barrier to Treat Brain Disorders$324,986
R41 · FY2021 · TR
Targeted therapeutic delivery to diseased lungs using enucleated mesenchymal stem cells$297,553
R43 · FY2021 · HL